A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice
- 1 March 2004
- Vol. 22 (9-10) , 1162-1171
- https://doi.org/10.1016/j.vaccine.2003.09.030
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Leishmania mexicanaandLeishmania major:Attenuation of Wild‐Type Parasites and Vaccination with the Attenuated LinesThe Journal of Infectious Diseases, 2003
- Characterization ofLeishmania donovaniAntigens Encapsulated in Liposomes That Induce Protective Immunity in BALB/c MiceInfection and Immunity, 2002
- Immune responses to an inactive vaccine against American cutaneous leishmaniasis together with granulocyte-macrophage colony-stimulating factorVaccine, 2002
- A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (S o Gon alo do Amaranto, RN)Vaccine, 2000
- The Adjuvant Effect of Interleukin-12 in a Vaccine Against Leishmania majorScience, 1994
- Immunological adjuvants: a role for liposomesImmunology Today, 1990
- Immunoadjuvant action of liposomes: comparison with other adjuvantsImmunology Letters, 1989
- New Perspectives on a Subclinical Form of Visceral LeishmaniasisThe Journal of Infectious Diseases, 1986
- Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.Journal of Clinical Investigation, 1985
- An Eight‐day Method for Screening Compounds against Leishmania donovani in the Golden Hamster*The Journal of Protozoology, 1958